Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Ascension of Targeted Covalent Inhibitors
Juswinder Singh
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 8, pp. 5886-5901
Closed Access | Times Cited: 127

Showing 1-25 of 127 citing articles:

Emerging and Re-emerging Warheads for Targeted Covalent Inhibitors: An Update
Laura Hillebrand, Xiaojun Julia Liang, Ricardo Augusto Massarico Serafim, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 10, pp. 7668-7758
Closed Access | Times Cited: 46
Quinones as Neuroprotective Agents
Ángel Cores, Noelia Carmona-Zafra, José Clerigué, et al.
Antioxidants (2023) Vol. 12, Iss. 7, pp. 1464-1464
Open Access | Times Cited: 45
An update on the discovery and development of reversible covalent inhibitors
Faridoon Faridoon, Raymond Ng, Guiping Zhang, et al.
Medicinal Chemistry Research (2023) Vol. 32, Iss. 6, pp. 1039-1062
Open Access | Times Cited: 44
Recent Advances in Covalent Drug Discovery
D. M. Schaefer, Xinlai Cheng
Pharmaceuticals (2023) Vol. 16, Iss. 5, pp. 663-663
Open Access | Times Cited: 42
Context-dependent role of SIRT3 in cancer
Jin Zhang, Jing Ye, Shiou Zhu, et al.
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 2, pp. 173-190
Closed Access | Times Cited: 15
Fragment-to-Lead Medicinal Chemistry Publications in 2022
Andrew J. Woodhead, Daniel A. Erlanson, Iwan J. P. de Esch, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 4, pp. 2287-2304
Closed Access | Times Cited: 15
New Opportunities for the Utilization of the Sulfoximine Group in Medicinal Chemistry from the Drug Designer's Perspective**
Ulrich Lücking
Chemistry - A European Journal (2022) Vol. 28, Iss. 56
Closed Access | Times Cited: 68
JDQ443, a Structurally Novel, Pyrazole-Based, Covalent Inhibitor of KRASG12C for the Treatment of Solid Tumors
Edwige Lorthiois, Marc Gerspacher, Kim S. Beyer, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 24, pp. 16173-16203
Closed Access | Times Cited: 65
PROTAC degraders as chemical probes for studying target biology and target validation
Václav Nêmec, Martin P. Schwalm, Susanne Müller, et al.
Chemical Society Reviews (2022) Vol. 51, Iss. 18, pp. 7971-7993
Closed Access | Times Cited: 51
Nitriles: an attractive approach to the development of covalent inhibitors
Vinícius Bonatto, Rafael F. Lameiro, Fernanda dos Reis Rocho, et al.
RSC Medicinal Chemistry (2022) Vol. 14, Iss. 2, pp. 201-217
Open Access | Times Cited: 40
Development of covalent inhibitors: Principle, design, and application in cancer
Lang Zheng, Yang Li, Defa Wu, et al.
MedComm – Oncology (2023) Vol. 2, Iss. 4
Open Access | Times Cited: 24
Target-based drug design strategies to overcome resistance to antiviral agents: opportunities and challenges
Shaoqing Du, Xueping Hu, Luis Menéndez‐Arias, et al.
Drug Resistance Updates (2024) Vol. 73, pp. 101053-101053
Closed Access | Times Cited: 14
Biospecific Chemistry for Covalent Linking of Biomacromolecules
Li Cao, Lei Wang
Chemical Reviews (2024) Vol. 124, Iss. 13, pp. 8516-8549
Open Access | Times Cited: 11
Demystifying Functional Parameters for Irreversible Enzyme Inhibitors
David E. Heppner, Blessing C. Ogboo, Daniel A. Urul, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 17, pp. 14693-14696
Closed Access | Times Cited: 11
Development of Highly Potent and Selective Covalent FGFR4 Inhibitors Based on SNAr Electrophiles
Moritz Schwarz, Maksym Kurkunov, Florian Wittlinger, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 8, pp. 6549-6569
Closed Access | Times Cited: 8
Morita–Baylis–Hillman Adduct Chemistry as a Tool for the Design of Lysine-Targeted Covalent Ligands
Marco Paolino, Giusy Tassone, Paolo Governa, et al.
ACS Medicinal Chemistry Letters (2025) Vol. 16, Iss. 3, pp. 397-405
Closed Access | Times Cited: 1
Peptide‐based covalent inhibitors of protein–protein interactions
Felix M. Paulussen, Tom N. Grossmann
Journal of Peptide Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 30
Chemical technology principles for selective bioconjugation of proteins and antibodies
Preeti Chauhan, V. Ragendu, Mohan Kumar, et al.
Chemical Society Reviews (2023) Vol. 53, Iss. 1, pp. 380-449
Closed Access | Times Cited: 19
Design, synthesis and bioevaluation of 1,2,4-thiadiazolidine-3,5-dione derivatives as potential GSK-3β inhibitors for the treatment of Alzheimer's disease
Yongxi Dong, Jun Lü, Shanhui Zhang, et al.
Bioorganic Chemistry (2023) Vol. 134, pp. 106446-106446
Closed Access | Times Cited: 17
Targeted protein degradation in drug development: Recent advances and future challenges
Jian H. Song, Mingzheng Hu, Jun Zhou, et al.
European Journal of Medicinal Chemistry (2023) Vol. 261, pp. 115839-115839
Closed Access | Times Cited: 17
Machine Learning Models to Interrogate Proteome-Wide Covalent Ligandabilities Directed at Cysteines
Ruibin Liu, Joseph Clayton, Mingzhe Shen, et al.
JACS Au (2024) Vol. 4, Iss. 4, pp. 1374-1384
Open Access | Times Cited: 6
Cryptic enzymatic assembly of peptides armed with β-lactone warheads
Guangcai Xu, Daniele Torri, Sebastian Cuesta-Hoyos, et al.
Nature Chemical Biology (2024) Vol. 20, Iss. 10, pp. 1371-1379
Open Access | Times Cited: 6
A chemical perspective on the modulation of TEAD transcriptional activities: Recent progress, challenges, and opportunities
Jianfeng Lou, Yuhang Lu, Jing Cheng, et al.
European Journal of Medicinal Chemistry (2022) Vol. 243, pp. 114684-114684
Closed Access | Times Cited: 22
Covalent chemical probes for protein kinases
Ricardo Augusto Massarico Serafim, Lisa Haarer, Júlia G. B. Pedreira, et al.
Current Research in Chemical Biology (2023) Vol. 3, pp. 100040-100040
Open Access | Times Cited: 15
Pitfalls and Considerations in Determining the Potency and Mutant Selectivity of Covalent Epidermal Growth Factor Receptor Inhibitors
Kristopher W. Hoyt, Daniel A. Urul, Blessing C. Ogboo, et al.
Journal of Medicinal Chemistry (2023) Vol. 67, Iss. 1, pp. 2-16
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top